New York, NY -- (SBWIRE) -- 03/06/2019 -- The global Nanomedicine market is expected to reach USD 343.8 billion by 2026, according to a new report by Reports and Data. Increased global incidence of cancer coupled with growing prevalence of cardiovascular diseases is likely to be the key factors governing market growth. Based on the WHO statistics, in 2018 around 18.07million new cases were registered for cancer in 2018. Additionally, cancer accounted for around 9.5 million deaths in 2018. The incidence of cancer was significantly high and lied around 48.4 percent in Asia Pacific.

Nanomedicine is being increasingly adopted for the treatment of various diseases including cancer and cardiovascular disease. Apart from improved efficacy and safety, factors such as bio-availability and ability to deliver diagnostic and therapeutic agents to targeted sites are expected to stimulate market growth.

Asia Pacific is expected to be a key revenue generating region in the forecast period. The market is projected to grow at a CAGR of 13.8% in the forecast period. This can be mainly associated with increasing incidence of cancer in the region. Based on estimates, along with high incidence of cancer as compared to other regions, the mortality rate of cancer in Asia is also significantly high. In 2018, the mortality rate was around 57.3 percent for Asia Pacific while it was around 20.3 percent for Europe. Increasing number of deaths of cancer patients is likely to lead to a rise in the adoption of nanomedicine in the region. Moreover, success of nanomedicines in the treatment of heart diseases is also expected to be a major factor affecting demand in the region.

In market segmentation by manufacturers, the Nanomedicine report covers the following
Arrowhead Pharmaceuticals Inc, AMAG Pharmaceuticals, Bio-Gate AG, Celgene Corporation, Johnson & Johnson, ABLYNX, Pfizer, Inc, Abbott, Leadiant Biosciences, Inc

Premium sample copy of Nanomedicine market report available on demand@ https://www.reportsanddata.com/sample-enquiry-form/1048

Nanomedicine Market split by Type, can be divided into:
- Therapeutics
- Regenerative Medicine
- In-vitro diagnostics
- In-vivo diagnostic
- Vaccines

Nanomedicine Market split by Drug Delivery System Outlook, can be divided into:
- Nanobots
- Nanoghosts
- Nanoclusters
- Nanobubbles
- Exosomes
- Injectable Nanoparticle Generator
- Dendrimers
- Liposomes
- Carbon nanotube
- Graphene
- Others

Nanomedicine Market split by Application, can be divided into:
- Oncology
- Infectious diseases
- Cardiology
- Orthopedics
- Others

Order Now (Customized report delivered as per your requirement)@ https://www.reportsanddata.com/checkout-form/1048

Further key findings from the report suggest:
- Dendrimers are expected to grow at a significant CAGR in the forecast period. These nano-devices have
emerged as a powerful class of nanomaterials owing to their unique features. These nanoparticles are
being opted as an efficient therapeutic strategy in the treatment of various neurological disorders.
- Asia Pacific market is forecasted to grow significantly in the coming years. Nanomedicines are
projected to be opted for the treatment of cancer and cardiovascular disease in the region.
Furthermore, efforts by government as well as medical institutes of the region are also anticipated to
foster market demand. For instance: Recently in 2018, the Indian Council of Medical Research announced
launching nano-medicine task force. The main aim of the scheme is to explore as well as convert nano-
enabled technologies towards clinical applications.
- Key participants include Arrowhead Pharmaceuticals Inc. AMAG Pharmaceuticals, Bio-Gate AG, Celgene
Corporation and Johnson & Johnson. Johnson & Johnson is a key player in the nanomedicine market. Under
its subsidiary NanoMedical systems, the company offers silicon-based medical nanotechnology products
which are utilized for providing improved biomarker detection for research, microbial surveillance,
and diagnostics. The company has manufacturing facilities located across the U.S., Europe, Asia
Pacific and Africa. As of 2017, while the company's Pharmaceutical segment accounted for around 36.3
percent of the revenue of the company, the medical devices segment accounted for 26.6 percent of the
total revenue.

Make an Enquiry@ https://www.reportsanddata.com/make-enquiry-form/1048

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering:
- United States
- Europe
- China
- Japan
- Southeast Asia
- India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

In this study, the years considered to estimate the market size of Nanomedicine are as follows:
History Year:2017
Base Year: 2018
Forecast Year 2018 to 2026

The Nanomedicine further aims at providing insight into:
- The major industry terms and forecasts the Nanomedicine, in terms of growth rate, value as well as segmentation on the basis of technology advancements, application share, and geography.
- The market size across major regions including North America, Asia Pacific, Europe, as well as Rest of the World.
- The micro markets with regards to company growth, prospects, as well as a contribution to the Nanomedicine industry.
- Data regarding the major drivers, restraining factors, challenges and opportunities affecting the growth rate of the industry.
- Information about growing investment pockets and competitive landscape for prominent players in the industry.
- The value chain pertaining to the Nanomedicine market.

The report provides answers to the questions below:
- `What will be the status of competitive development including expansion, product and service launches and other developments?
- How much funds are major companies rolling out for their research and development activities in the Nanomedicine space?
- Based on the end user, which category of the Nanomedicine is projected to grow rapidly at the highest CAGR from 2019 to 2026?
- Among product and service types, which segment will lead the Nanomedicine industry during the forecast period?
- Which region is expected to make more sales from 2019 to 2026?

Key Points From TOC:
Chapter 1. Market Synopsis
Chapter 2. Executive Summary
Chapter 3. Indicative Metrics
Chapter 4. Nanomedicine Market Segmentation & Impact Analysis
Chapter 5. Nanomedicine Market By Type of Service Insights & Trends
Chapter 6. Nanomedicine Market By Industry Verticals Insights & Trends
Chapter 7. Nanomedicine Market By Size of Organization Insights & Trends
Chapter 8. Nanomedicine Market Regional Outlook
Chapter 9. Competitive Landscape
Chapter 10. Company Profiles
Browse complete Nanomedicine report description And Full TOC@ https://www.reportsanddata.com/report-detail/nanomedicine-market

About Us:
We are a boutique market intelligence and strategic consulting firm dedicated to make an meaningful impact on businesses across the globe. Our stellar estimation and forecasting models have earned recognition across majority of the business forum across the globe. Our services are arrayed over diverse sectors and industries looking to expand in alternative regions and products.

Contact Us:
John Watson
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
News: : www.reportsanddata.com/market-news